Boston Scientific Corp (BSX)
74.65
+0.10
(+0.13%)
USD |
NYSE |
May 17, 16:00
74.66
+0.01
(+0.01%)
After-Hours: 20:00
Boston Scientific Free Cash Flow: 1.553B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 1.553B |
December 31, 2023 | 1.703B |
September 30, 2023 | 1.615B |
June 30, 2023 | 1.422B |
March 31, 2023 | 1.172B |
December 31, 2022 | 914.00M |
September 30, 2022 | 524.00M |
June 30, 2022 | 583.00M |
March 31, 2022 | 918.00M |
December 31, 2021 | 1.316B |
September 30, 2021 | 1.602B |
June 30, 2021 | 1.737B |
March 31, 2021 | 1.374B |
December 31, 2020 | 986.00M |
September 30, 2020 | 1.131B |
June 30, 2020 | 997.00M |
March 31, 2020 | 937.00M |
December 31, 2019 | 1.375B |
September 30, 2019 | 621.00M |
June 30, 2019 | 651.00M |
March 31, 2019 | 51.00M |
December 31, 2018 | -178.00M |
September 30, 2018 | 496.00M |
June 30, 2018 | 457.00M |
March 31, 2018 | 1.153B |
Date | Value |
---|---|
December 31, 2017 | 976.00M |
September 30, 2017 | 790.00M |
June 30, 2017 | 338.00M |
March 31, 2017 | 471.00M |
December 31, 2016 | 674.00M |
September 30, 2016 | 368.00M |
June 30, 2016 | 808.00M |
March 31, 2016 | 479.00M |
December 31, 2015 | 178.00M |
September 30, 2015 | 443.00M |
June 30, 2015 | 395.00M |
March 31, 2015 | 611.00M |
December 31, 2014 | 984.00M |
September 30, 2014 | 808.00M |
June 30, 2014 | 706.00M |
March 31, 2014 | 822.00M |
December 31, 2013 | 821.00M |
September 30, 2013 | 984.00M |
June 30, 2013 | 1.005B |
March 31, 2013 | 1.013B |
December 31, 2012 | 1.032B |
September 30, 2012 | 964.00M |
June 30, 2012 | 1.052B |
March 31, 2012 | 1.005B |
December 31, 2011 | 693.00M |
Free Cash Flow Range, Past 5 Years
524.00M
Minimum
Sep 2022
1.737B
Maximum
Jun 2021
1.157B
Average
1.152B
Median
Free Cash Flow Benchmarks
ResMed Inc | 1.071B |
Stryker Corp | 2.858B |
Align Technology Inc | 491.58M |
Abbott Laboratories | 4.923B |
Axonics Inc | -16.29M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 164.00M |
Cash from Investing (Quarterly) | -285.00M |
Cash from Financing (Quarterly) | 1.569B |
Free Cash Flow Per Share (Quarterly) | -0.0547 |
Free Cash Flow to Equity (Quarterly) | -1.599B |
Free Cash Flow to Firm (Quarterly) | -25.05M |
Free Cash Flow Yield | 1.41% |